Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently developed a new build-up of fluid around the lung and are already scheduled to have a procedure to drain that fluid
- People who are 18 years of age or older
- People who are able to understand and agree to participate by signing a consent form
Who may not be able to join:
- People who have previously had tuberculosis (TB) affecting the lining around the lung on the same side, or who have had any treatments injected into that same pleural space (such as talc or clot-dissolving medicines) — note that people with a history of TB in other parts of the body who have completed their TB treatment may still be considered eligible (confirm with trial site)
- People who have previously had surgery involving the same side of the chest, including procedures to remove the lung lining, seal the pleural space, or remove part of the lung
- People who have been taking two or more TB medications at the same time for more than 7 days in a row within the past 3 months — the medications this refers to include isoniazid, rifampicin, pyrazinamide, ethambutol, amikacin, streptomycin, levofloxacin, moxifloxacin, and linezolid
- People who have not been able to provide consent to participate in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ka Pang Chan, MBChB, Prince of Wales Hospital, Shatin, Hong Kong
Phone: 35052211
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
diagnostic accuracy of the new MTB cfDNA assay
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.